Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

No Effect of Etodolac, a COX Inhibitor, on Platelet Function in Healthy Volunteers.

Wolfgang C. Korte, MD, Giuseppe Plebani, MD

Blood (2007) 110 (11): 2098.

https://doi.org/10.1182/blood.V110.11.2098.2098

Published: 2007

Journal Articles

SDX-308, a Structural Analog of Etodolac, Inhibits NF-κB Activity Resulting in Significant Inhibition of Osteoclast Formation/Activity and Multiple Myeloma Cell Growth.

Rentian Feng, PhD, Gulsum Anderson, PhD, Guozhi Xiao, MD, PhD, Gary Elliott, PhD, Lorenzo M. Leoni, MD, Markus Y. Mapara, MD, PhD, David Roodman, MD, PhD, Suzanne Lentzsch, MD, PhD

Blood (2006) 108 (11): 3456.

https://doi.org/10.1182/blood.V108.11.3456.3456

Published: 2006

Journal Articles

Novel Etodolac Analog SDX-308 (CEP-18082) Induces Cytotoxicity in Multiple Myeloma Cells Associated with Inhibition of Wnt/β-Catenin Pathway.

Hiroshi Yasui, MD, PhD, Teru Hideshima, M.D., Ph.D., Hiroshi Ikeda, M.D., Ph.D., Enrique M. Ocio, M.D., Ph.D., Tanyel Kiziltepe, Ph.D., Sonia Vallet, M.D., Ph.D., Yutaka Okawa, M.D., Ph.D., Shweta Chhetri, Kumar Sukhdeo, Kenji Ishitsuka, M.D., Ph.D., Klaus Podar, M.D., Ph.D., Noopur Raje, M.D., Ph.D., Dharminder Chauhan, Ph.D., Daniel R. Cattasco, M.D., Ph.D., Kenneth C. Anderson, M.D.

Blood (2006) 108 (11): 5005.

https://doi.org/10.1182/blood.V108.11.5005.5005

Published: 2006

Journal Articles

SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth

Rentian Feng, Gülsüm Anderson, Guozhi Xiao, Gary Elliott, Lorenzo Leoni, Markus Y. Mapara, G. David Roodman, Suzanne Lentzsch

Blood (2006) 109 (5): 2130–2138.

https://doi.org/10.1182/blood-2006-07-027458

Published: 2006

Includes: Supplemental data

Journal Articles

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Miki Kobayashi, MD, Satoki Nakamura, MD, PhD, Kiyoshi Shibata, Naohi Sahara, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2005) 106 (11): 4825.

https://doi.org/10.1182/blood.V106.11.4825.4825

Published: 2005

Journal Articles

Cytotoxic Effect of R-Etodolac (SDX-101) in Combination with Purine Analogues or Monoclonal Antibodies on Ex-Vivo B-Cell Chronic Lymphocytic Leukemia Cells.

Pawel Robak, Anna Linke, Barbara Cebula, Lorenzo M. Leoni, Tadeusz Robak, Piotr Smolewski

Blood (2005) 106 (11): 2122.

https://doi.org/10.1182/blood.V106.11.2122.2122

Published: 2005

Journal Articles

R-Etodolac and a Novel Indole-Pyran Structural Analog, SDX-308, Induce Cytotoxicity and Overcome Drug Resistance in Multiple Myeloma.

Hiroshi Yasui, Teru Hideshima, Paola Neri, Janice Jin, Tanyel Kiziltepe, Norihiko Shiraishi, Kenji Ishitsuka, Catley P. Laurence, Noopur Raje, Klaus Podar, Pierfrancesco Tassone, Dharminder Chauhan, Paul G. Richardson, Lorenzo M. Leoni, Sarath Kanekal, Gary T. Elliott, Nikhil C. Munshi, Kenneth C. Anderson

Blood (2005) 106 (11): 1580.

https://doi.org/10.1182/blood.V106.11.1580.1580

Published: 2005

Journal Articles

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

Hiroshi Yasui, Teru Hideshima, Makoto Hamasaki, Aldo M. Roccaro, Norihiko Shiraishi, Shaji Kumar, Pierfrancesco Tassone, Kenji Ishitsuka, Noopur Raje, Yu-Tzu Tai, Klaus Podar, Dharminder Chauhan, Lorenzo M. Leoni, Sarath Kanekal, Gary Elliott, Nikhil C. Munshi, Kenneth C. Anderson

Blood (2005) 106 (2): 706–712.

https://doi.org/10.1182/blood-2005-02-0838

Published: 2005

Journal Articles

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Satoki Nakamura, MD, PhD, Miki Kobayashi, MD, Kiyoshi Shibata, Naohi Sahara, MD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2004) 104 (11): 4836.

https://doi.org/10.1182/blood.V104.11.4836.4836

Published: 2004

Journal Articles

Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac).

Lorenzo M. Leoni, Ph.D., Brian Crain, Brandi Bailey, Mimi Phillips, Heather Bendall, Ph.D., Qi Chao, Ph.D., Jack Reifert, Christina Niemeyer, Ph.D., Gary Elliott, Ph.D.

Blood (2004) 104 (11): 3411.

https://doi.org/10.1182/blood.V104.11.3411.3411

Published: 2004

Journal Articles

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac

Francis A. Nardella, Jane A. LeFevre

Blood (2002) 99 (7): 2625–2626.

https://doi.org/10.1182/blood.V99.7.2625

Published: 2002

NARROW

No Effect of Etodolac, a COX Inhibitor, on Platelet Function in Healthy Volunteers.

SDX-308, a Structural Analog of Etodolac, Inhibits NF-κB Activity Resulting in Significant Inhibition of Osteoclast Formation/Activity and Multiple Myeloma Cell Growth.

Novel Etodolac Analog SDX-308 (CEP-18082) Induces Cytotoxicity in Multiple Myeloma Cells Associated with Inhibition of Wnt/β-Catenin Pathway.

SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Cytotoxic Effect of R-Etodolac (SDX-101) in Combination with Purine Analogues or Monoclonal Antibodies on Ex-Vivo B-Cell Chronic Lymphocytic Leukemia Cells.

R-Etodolac and a Novel Indole-Pyran Structural Analog, SDX-308, Induce Cytotoxicity and Overcome Drug Resistance in Multiple Myeloma.

SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Mechanism of Action and Safety of Second Generation Analogs of SDX-101 (R-Etodolac).

Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only